Is a continued treatment with alendronate for another two years after a preceding therapy with bisphosphonates of at least four years able to reduce the incidence of new osteoporotic fractures in patients at high fracture risk compared to a therapy-free interval?
The purpose of this study is to evaluate the efficacy and safety of bisphosphonates in long term treatment of osteoporosis.